| | Conditions & Treatments | Burns
The AGS Beers Criteria®: Clinician's Guide to Safer Prescribing for Older Adults
The American Geriatrics Society (AGS) Beers Criteria® (2023 update) is the most widely used explicit tool for identifying potentially inappropriate medications (PIMs) in adults ≥65. It is not a "do not use" list — it is a decision-support framework to reduce adverse drug events (ADEs), hospitalizations, and mortality through informed prescribing.
Structure: 5 Categories
- PIMs for Most Older Adults (Table 2): Avoid regardless of condition (e.g., benzodiazepines, non-benzodiazepine hypnotics, first-gen antihistamines, anticholinergics, skeletal muscle relaxants, sliding-scale insulin, PPIs >8 weeks without indication).
- PIMs for Specific Conditions (Table 3): Avoid in certain diseases (e.g., NSAIDs in heart failure/CKD/ulcer history; antipsychotics in dementia; stimulants in anxiety/insomnia).
- Drugs to Use with Caution (Table 4): Benefit may outweigh risk with monitoring (e.g., aspirin >80, anticoagulants, SNRIs, vasodilators, hypoglycemics).
- Drug-Drug Interactions (Table 5): Clinically important pairs (e.g., ACEi + K-sparing diuretic = hyperkalemia; warfarin + NSAID = bleed; opioid + benzo = respiratory depression).
- Dose Adjustment for Renal Impairment (Table 6): eGFR-based dosing for 30+ drugs (e.g., gabapentin, metformin, DOACs, antibiotics).
Key 2023 Updates
- Added: Gabapentinoids (gabapentin, pregabalin) — avoid initiating for chronic non-cancer pain; taper if possible (↑ falls, sedation, misuse).
- Added: SGLT2 inhibitors — use with caution in frail/low BMI (euglycemic DKA risk).
- Clarified: Antipsychotics in dementia — avoid except for severe agitation/psychosis with safety risk; time-limited, documented informed consent.
- Updated: Anticholinergic burden — cumulative ACB scale ≥3 = high risk.
- New: Deprescribing algorithms for PPIs, benzodiazepines, statins, bisphosphonates.
Clinical Workflow Integration
- Screen: Run Beers/STOPP/START at every visit via EHR clinical decision support (CDS).
- Prioritize: High-severity PIMs (fall risk, anticholinergic, CNS) + patient-reported symptoms.
- Communicate: "This medication may increase your risk of falls/confusion. Can we try…?"
- Deprescribe: Taper plan, monitor, restart only if necessary.
- Document: Reason for continuing PIM if benefit > risk (shared decision).
Beyond Beers: Complementary Tools
- STOPP/START v3: More condition-specific; includes omissions (START).
- MedStopper: Web/app algorithm ranking drugs by "stop priority."
- FORTA: Fit fOR The Aged — classifies drugs A (indispensable) to D (avoid).
- Drug Burden Index (DBI): Quantifies anticholinergic/sedative load.
Limitations
- Not exhaustive — clinical judgment paramount.
- Based on evidence quality (often low for oldest-old).
- Does not capture all pharmacokinetic changes of aging.
- US-centric; international versions exist (EU(7)-PIM, PRISCUS, NORGEP).
The Beers Criteria is a starting point for conversation, not a verdict. Safer prescribing = systematic review + patient-centered deprescribing + interdisciplinary collaboration.
Burns - Related Articles
- Daily Moisturizer Use: Frequency and Timing Guide for Day and Night Creams
- First-Degree vs. Second-Degree Burns: Key Differences in Depth, Symptoms, and Healing
- Frostbite Treatment: Symptoms, Stages & Home Care
- Firefighter Protective Gear: Materials & Design Features
- Oil Pulling at Night: Benefits, Evidence, and How-To Guide
- Muriatic Acid Burns: Treatment, First Aid & Safety
- Finger Burn Treatment: Soothe Pain & Promote Healing
